Ted Yednock sold $5,331 of ANNX
EVP & CHIEF INNOVATION OFFICER at Annexon, Inc.. 1,783 shares at an average of $2.99, traded Feb 13, 2025, filed Feb 18, 2025.
Score components
- +15RoleOfficer
- 0Trade size$5k at market
- 0Share of holdings soldSold 2.5% of holdings
- +15Cluster6 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-004432, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 13, 2025 | SOpen-market sale Common Stock | -1,783 | $2.99 | $5,331 | 69,582 | Feb 18, 2025 |
Related signals
Other insiders at Annexon, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 46Moderate | ANNXbuy Annexon, Inc. | Douglas Love PRESIDENT AND CEO | $100k 26,065 shares | +7% | |
| 14Weak | Annexon, Inc. | William H. Carson director | $45k 8,000 shares | +15% | |
| 35Weak | Annexon, Inc. | Dean Richard Artis EVP & CHIEF SCIENTIFIC OFFICER | $32k 5,894 shares | -3% | |
| 42Moderate | Annexon, Inc. | Jennifer Lew EVP & CHIEF FINANCIAL OFFICER | $30k 5,565 shares | -3% | |
| 35Weak | Annexon, Inc. | Jamie Dananberg CHIEF MEDICAL OFFICER | $32k 5,820 shares | -4% | |
| 30Weak | Annexon, Inc. | Michael Overdorf EVP & CHIEF BUSINESS OFFICER | $24k 4,339 shares | -2% | |
| 35Weak | Annexon, Inc. | Ted Yednock EVP & CHIEF INNOVATION OFFICER | $30k 5,566 shares | -3% | |
| 35Weak | Annexon, Inc. | Dean Richard Artis EVP & CHIEF SCIENTIFIC OFFICER | $27k 5,290 shares | -4% | |
| 43Moderate | Annexon, Inc. | Jennifer Lew EVP & CHIEF FINANCIAL OFFICER | $40k 7,851 shares | -6% | |
| 35Weak | Annexon, Inc. | Jamie Dananberg CHIEF MEDICAL OFFICER | $27k 5,290 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.